Publicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (12)

2022

  1. Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs

    Cancers, Vol. 14, Núm. 19

  2. Limited genomic reconstruction of SARS-CoV-2 transmission history within local epidemiological clusters

    Virus Evolution, Vol. 8, Núm. 1

2021

  1. Omics-based biomarkers for CRC

    Foundations of Colorectal Cancer (Elsevier), pp. 249-263

  2. Population-based universal screening for CRC: Secondary prevention

    Foundations of Colorectal Cancer (Elsevier), pp. 45-56

  3. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

  4. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. CD26-Related Serum Biomarkers: SCD26 Protein, DPP4 Activity, and Anti-CD26 Isotype Levels in a Colorectal Cancer-Screening Context

    Disease Markers, Vol. 2020

2015

  1. Cribado poblacional universal de CCR. Prevención secundaria

    Abordaje multidisciplinar de cáncer colorrectal (Andavira), pp. 31-49

2014

  1. Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients

    PLoS ONE, Vol. 9, Núm. 9

2010

  1. Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas

    BMC Cancer, Vol. 10

2009

  1. Soluble CD26 levels and its association to epidemiologic parameters in a sample population

    Disease Markers, Vol. 27, Núm. 6, pp. 311-316

2008

  1. How the measurements of a few serum markers can be combined to enhance their clinical values in the management of cancer

    Anticancer Research, Vol. 28, Núm. 4 C, pp. 2333-2341